Global trader supply Rapamycin 53123-88-9 exporter CAS NO.53123-88-9

MSDS/COA Download
Min.Order: 1 Gram
Payment Terms: T/T

Product Details

Keywords

Supply Rapamycin
global trader Rapamycin
Rapamycin exporter

Quick Details

ProName: Global trader supply Rapamycin 53123-8...
CasNo: 53123-88-9
Molecular Formula: C51H79NO13
Appearance: White or almost white crystalline powd...
Application: 53123-88-9 ;API
DeliveryTime: promptly
PackAge: as customer required
Port: SHANGHAI
ProductionCapacity: 3 Kilogram/Month
Purity: 98%min
Storage: In a cold, dry place
Transportation: As a normal goods
LimitNum: 1 Gram
Related Substances: 1.0%Max
Residue on Ignition: 0.2%Max
Heavy Metal: 0.002%Max
Valid Period: 2years
White or almost white crystalline powder: assay is 98%min

Superiority

Global trader supply Rapamycin 53123-88-9 exporter

Rapamycin (RAPA) has similar side effects as FK506. In a large number of clinical trials, it has been found that its side effects are dose-dependent and reversible. The therapeutic dose of RAPA has not been found to have obvious nephrotoxicity and no gingival hyperplasia. The main side effects include headache, nausea, dizziness, nose bleeding, joint pain. Laboratory abnormalities include: thrombocytopenia, leukopenia, hemoglobin reduction, hypertriglyceridemia, hypercholesterolemia, hyperglycemia, elevated liver enzymes (SGOT, SGPT), elevated lactate dehydrogenase, low potassium, Hypomagnesemia and so on. Recently, it has been reported that taking RAPA can cause eyelid swelling, and the reason for the lower plasma phosphate level is believed to be that RAPA-based immunosuppressive therapy prolongs the excretion of phosphate from the transplanted kidney. Like other immunosuppressants, RAPA has an increased chance of infection. It has been reported that it has a tendency to increase pneumonia, but the occurrence of other opportunistic infections is not significantly different from CsA.